You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
davidhasan466
The median survival time and the 2-year survival rate were 30.5 months and 61.4% for the gefitinib group, Gefitinib Cost differs from brands, manufacturers, and suppliers so if you want to order then contact us for more details.as compared with 23.6 months and 46.7%, respectively, for the carboplatin–paclitaxel group (P=0.31) (Figure 2C). Neither sex nor clinical stage had a significant effect on overall survival.Geftinat 250mg Tablet is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.